_id
69130c5cccc777a4e85d7cfa
Ticker
KYMR
Name
Kymera Therapeutics Inc
Exchange
NASDAQ
Address
500 North Beacon Street, Watertown, MA, United States, 02472
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.kymeratx.com
Description
Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa and atopic dermatitis. The company also develops STAT6, a type 2 inflammation in allergic and atopic diseases; and TYK2 to treat autoimmune and inflammatory diseases. The company has a strategic alliance with Sanofi S.A. for the development of drug candidates targeting IRAK4 outside of the oncology and immuno-oncology fields. Kymera Therapeutics, Inc. was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
Last Close
87.81
Volume
325951
Current Price
89.68
Change
2.1295979956724795
Last Updated
2025-12-01T10:04:55.428Z
Image
data:image/webp;base64,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
Ipo Date
2020-08-21T00:00:00.000Z
Market Cap
4883899392
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.4706272727272728
Sentiment Sources
11
Rating
4.55
Target Price
77.5909
Strong Buy
14
Buy
3
Hold
3
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
2764000
Cost Of Revenue
74094000
Gross Profit
-71330000
Operating Expenses
21191000
Operating Income
-92521000
Interest Expense
98000
Pretax Income
-82175000
Net Income
-82175000
Eps
-0.941291303444298
Dividends Per Share
-
Shares Outstanding
71949027
Income Tax Expense
-
EBITDA
-79326000
Operating Margin
-3347.358900144718
Total Other Income Expense Net
10346000
Cash
112949000
Short Term Investments
392733000
Receivables
-
Inventories
-
Total Current Assets
528298000
Property Plant Equipment
88075000
Total Assets
1102044000
Payables
5506000
Short Term Debt
13743000
Long Term Debt
-
Total Liabilities
155786000
Equity
946258000
Depreciation
2149000
Change In Working Capital
38478000
Cash From Operations
-27110000
Capital Expenditures
181000
Cash From Investing
-235299000
Cash From Financing
39510000
Net Change In Cash
-222899000
PE
-
PB
8.273736812243596
ROE
-8.684206632863342
ROA
-7.4565988290848635
FCF
-27291000
Fcf Percent
-9.873733719247467
Piotroski FScore
1
Health Score
27
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
4
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
2764000
Quarters > 0 > income Statement > cost Of Revenue
74094000
Quarters > 0 > income Statement > gross Profit
-71330000
Quarters > 0 > income Statement > operating Expenses
21191000
Quarters > 0 > income Statement > operating Income
-92521000
Quarters > 0 > income Statement > interest Expense
98000
Quarters > 0 > income Statement > pretax Income
-82175000
Quarters > 0 > income Statement > net Income
-82175000
Quarters > 0 > income Statement > eps
-0.941291303444298
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
87300286
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-79326000
Quarters > 0 > income Statement > operating Margin
-3347.358900144718
Quarters > 0 > income Statement > total Other Income Expense Net
10346000
Quarters > 0 > balance Sheet > cash
112949000
Quarters > 0 > balance Sheet > short Term Investments
392733000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
528298000
Quarters > 0 > balance Sheet > property Plant Equipment
88075000
Quarters > 0 > balance Sheet > total Assets
1102044000
Quarters > 0 > balance Sheet > payables
5506000
Quarters > 0 > balance Sheet > short Term Debt
13743000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
155786000
Quarters > 0 > balance Sheet > equity
946258000
Quarters > 0 > cash Flow > net Income
-82175000
Quarters > 0 > cash Flow > depreciation
2149000
Quarters > 0 > cash Flow > change In Working Capital
38478000
Quarters > 0 > cash Flow > cash From Operations
-27110000
Quarters > 0 > cash Flow > capital Expenditures
181000
Quarters > 0 > cash Flow > cash From Investing
-235299000
Quarters > 0 > cash Flow > cash From Financing
39510000
Quarters > 0 > cash Flow > net Change In Cash
-222899000
Quarters > 0 > ratios > PE
-0.941291303444298
Quarters > 0 > ratios > PB
8.273736812243596
Quarters > 0 > ratios > ROE
-8.684206632863342
Quarters > 0 > ratios > ROA
-7.4565988290848635
Quarters > 0 > ratios > FCF
-27291000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-9.873733719247467
Quarters > 0 > health Score
27
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
11476000
Quarters > 1 > income Statement > cost Of Revenue
2084000
Quarters > 1 > income Statement > gross Profit
9392000
Quarters > 1 > income Statement > operating Expenses
93949000
Quarters > 1 > income Statement > operating Income
-84557000
Quarters > 1 > income Statement > interest Expense
108000
Quarters > 1 > income Statement > pretax Income
-76614000
Quarters > 1 > income Statement > net Income
-76614000
Quarters > 1 > income Statement > eps
-0.952325253368872
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
80449405
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-74422000
Quarters > 1 > income Statement > operating Margin
-736.8159637504357
Quarters > 1 > income Statement > total Other Income Expense Net
7943000
Quarters > 1 > balance Sheet > cash
335816000
Quarters > 1 > balance Sheet > short Term Investments
329629000
Quarters > 1 > balance Sheet > receivables
40000000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
728327000
Quarters > 1 > balance Sheet > property Plant Equipment
94617000
Quarters > 1 > balance Sheet > total Assets
1131068000
Quarters > 1 > balance Sheet > payables
5781000
Quarters > 1 > balance Sheet > short Term Debt
13666000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
159588000
Quarters > 1 > balance Sheet > equity
971480000
Quarters > 1 > cash Flow > net Income
-76614000
Quarters > 1 > cash Flow > depreciation
2084000
Quarters > 1 > cash Flow > change In Working Capital
1351000
Quarters > 1 > cash Flow > cash From Operations
-59884000
Quarters > 1 > cash Flow > capital Expenditures
695000
Quarters > 1 > cash Flow > cash From Investing
60021000
Quarters > 1 > cash Flow > cash From Financing
245726000
Quarters > 1 > cash Flow > net Change In Cash
245863000
Quarters > 1 > ratios > PE
-0.952325253368872
Quarters > 1 > ratios > PB
7.426506608885412
Quarters > 1 > ratios > ROE
-7.886317783176184
Quarters > 1 > ratios > ROA
-6.773598050691912
Quarters > 1 > ratios > FCF
-60579000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-5.278755663994423
Quarters > 1 > health Score
27
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
22100000
Quarters > 2 > income Statement > cost Of Revenue
2048000
Quarters > 2 > income Statement > gross Profit
22100000
Quarters > 2 > income Statement > operating Expenses
96526000
Quarters > 2 > income Statement > operating Income
-74426000
Quarters > 2 > income Statement > interest Expense
72000
Quarters > 2 > income Statement > pretax Income
-65581000
Quarters > 2 > income Statement > net Income
-65581000
Quarters > 2 > income Statement > eps
-0.8182637374535898
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
80146531
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-63461000
Quarters > 2 > income Statement > operating Margin
-336.7692307692308
Quarters > 2 > income Statement > total Other Income Expense Net
8845000
Quarters > 2 > balance Sheet > cash
89966000
Quarters > 2 > balance Sheet > short Term Investments
373184000
Quarters > 2 > balance Sheet > receivables
20000000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
500951000
Quarters > 2 > balance Sheet > property Plant Equipment
95906000
Quarters > 2 > balance Sheet > total Assets
918312000
Quarters > 2 > balance Sheet > payables
10263000
Quarters > 2 > balance Sheet > short Term Debt
13240000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
132079000
Quarters > 2 > balance Sheet > equity
786233000
Quarters > 2 > cash Flow > net Income
-65581000
Quarters > 2 > cash Flow > depreciation
2048000
Quarters > 2 > cash Flow > change In Working Capital
-27325000
Quarters > 2 > cash Flow > cash From Operations
-79150000
Quarters > 2 > cash Flow > capital Expenditures
467000
Quarters > 2 > cash Flow > cash From Investing
48615000
Quarters > 2 > cash Flow > cash From Financing
258000
Quarters > 2 > cash Flow > net Change In Cash
-30277000
Quarters > 2 > ratios > PE
-0.8182637374535898
Quarters > 2 > ratios > PB
9.14174411412393
Quarters > 2 > ratios > ROE
-8.341166041109952
Quarters > 2 > ratios > ROA
-7.141472614971818
Quarters > 2 > ratios > FCF
-79617000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-3.602579185520362
Quarters > 2 > health Score
26
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
7394000
Quarters > 3 > income Statement > cost Of Revenue
1973000
Quarters > 3 > income Statement > gross Profit
7394000
Quarters > 3 > income Statement > operating Expenses
88149000
Quarters > 3 > income Statement > operating Income
-80755000
Quarters > 3 > income Statement > interest Expense
59000
Quarters > 3 > income Statement > pretax Income
-70752000
Quarters > 3 > income Statement > net Income
-70752000
Quarters > 3 > income Statement > eps
-0.884539027421635
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
79987426
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-68706000
Quarters > 3 > income Statement > operating Margin
-1092.1693264809305
Quarters > 3 > income Statement > total Other Income Expense Net
10003000
Quarters > 3 > balance Sheet > cash
120256000
Quarters > 3 > balance Sheet > short Term Investments
368488000
Quarters > 3 > balance Sheet > receivables
947000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
510268000
Quarters > 3 > balance Sheet > property Plant Equipment
97864000
Quarters > 3 > balance Sheet > total Assets
978035000
Quarters > 3 > balance Sheet > payables
5989000
Quarters > 3 > balance Sheet > short Term Debt
13112000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
142416000
Quarters > 3 > balance Sheet > equity
835619000
Quarters > 3 > cash Flow > net Income
-70752000
Quarters > 3 > cash Flow > depreciation
1987000
Quarters > 3 > cash Flow > change In Working Capital
3402000
Quarters > 3 > cash Flow > cash From Operations
-61784000
Quarters > 3 > cash Flow > capital Expenditures
936000
Quarters > 3 > cash Flow > cash From Investing
68568000
Quarters > 3 > cash Flow > cash From Financing
2765000
Quarters > 3 > cash Flow > net Change In Cash
9549000
Quarters > 3 > ratios > PE
-0.884539027421635
Quarters > 3 > ratios > PB
8.58438159457839
Quarters > 3 > ratios > ROE
-8.467016666686613
Quarters > 3 > ratios > ROA
-7.234096939271089
Quarters > 3 > ratios > FCF
-62720000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-8.482553421693265
Quarters > 3 > health Score
27
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
47072000
Annuals > 0 > income Statement > cost Of Revenue
7373000
Annuals > 0 > income Statement > gross Profit
47072000
Annuals > 0 > income Statement > operating Expenses
308707000
Annuals > 0 > income Statement > operating Income
-261635000
Annuals > 0 > income Statement > interest Expense
249000
Annuals > 0 > income Statement > pretax Income
-223858000
Annuals > 0 > income Statement > net Income
-223858000
Annuals > 0 > income Statement > eps
-2.9830236507543955
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
75043991
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-216236000
Annuals > 0 > income Statement > operating Margin
-555.8187457511897
Annuals > 0 > income Statement > total Other Income Expense Net
37777000
Annuals > 0 > balance Sheet > cash
120256000
Annuals > 0 > balance Sheet > short Term Investments
368488000
Annuals > 0 > balance Sheet > receivables
947000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
510268000
Annuals > 0 > balance Sheet > property Plant Equipment
97864000
Annuals > 0 > balance Sheet > total Assets
978035000
Annuals > 0 > balance Sheet > payables
5989000
Annuals > 0 > balance Sheet > short Term Debt
13112000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
142416000
Annuals > 0 > balance Sheet > equity
835619000
Annuals > 0 > cash Flow > net Income
-223858000
Annuals > 0 > cash Flow > depreciation
7373000
Annuals > 0 > cash Flow > change In Working Capital
-23970000
Annuals > 0 > cash Flow > cash From Operations
-194501000
Annuals > 0 > cash Flow > capital Expenditures
12838000
Annuals > 0 > cash Flow > cash From Investing
-404077000
Annuals > 0 > cash Flow > cash From Financing
608851000
Annuals > 0 > cash Flow > net Change In Cash
10273000
Annuals > 0 > ratios > PE
-2.9830236507543955
Annuals > 0 > ratios > PB
6.0960630491647505
Annuals > 0 > ratios > ROE
-26.78948180929347
Annuals > 0 > ratios > ROA
-22.888546933391954
Annuals > 0 > ratios > FCF
-207339000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-4.404720428280082
Annuals > 0 > health Score
26
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
78592000
Annuals > 1 > income Statement > cost Of Revenue
189081000
Annuals > 1 > income Statement > gross Profit
78592000
Annuals > 1 > income Statement > operating Expenses
244122000
Annuals > 1 > income Statement > operating Income
-165530000
Annuals > 1 > income Statement > interest Expense
196000
Annuals > 1 > income Statement > pretax Income
-146962000
Annuals > 1 > income Statement > net Income
-146962000
Annuals > 1 > income Statement > eps
-2.517960139431002
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
58365499
Annuals > 1 > income Statement > income Tax Expense
18764000
Annuals > 1 > income Statement > EBITDA
-143201000
Annuals > 1 > income Statement > operating Margin
-210.61940146579806
Annuals > 1 > income Statement > total Other Income Expense Net
18568000
Annuals > 1 > balance Sheet > cash
109966000
Annuals > 1 > balance Sheet > short Term Investments
264915000
Annuals > 1 > balance Sheet > receivables
18762000
Annuals > 1 > balance Sheet > inventories
1
Annuals > 1 > balance Sheet > total Current Assets
405317000
Annuals > 1 > balance Sheet > property Plant Equipment
101079000
Annuals > 1 > balance Sheet > total Assets
575759000
Annuals > 1 > balance Sheet > payables
7075000
Annuals > 1 > balance Sheet > short Term Debt
6345000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
180788000
Annuals > 1 > balance Sheet > equity
394971000
Annuals > 1 > cash Flow > net Income
-146962000
Annuals > 1 > cash Flow > depreciation
3565000
Annuals > 1 > cash Flow > change In Working Capital
9253000
Annuals > 1 > cash Flow > cash From Operations
-102826000
Annuals > 1 > cash Flow > capital Expenditures
34480000
Annuals > 1 > cash Flow > cash From Investing
139886000
Annuals > 1 > cash Flow > cash From Financing
4192000
Annuals > 1 > cash Flow > net Change In Cash
41252000
Annuals > 1 > ratios > PE
-2.517960139431002
Annuals > 1 > ratios > PB
10.030736616409811
Annuals > 1 > ratios > ROE
-37.208301368961266
Annuals > 1 > ratios > ROA
-25.524915806787213
Annuals > 1 > ratios > FCF
-137306000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-1.747073493485342
Annuals > 1 > health Score
26
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
46826000
Annuals > 2 > income Statement > cost Of Revenue
2977000
Annuals > 2 > income Statement > gross Profit
46826000
Annuals > 2 > income Statement > operating Expenses
208082000
Annuals > 2 > income Statement > operating Income
-161256000
Annuals > 2 > income Statement > interest Expense
176000
Annuals > 2 > income Statement > pretax Income
-154808000
Annuals > 2 > income Statement > net Income
-154808000
Annuals > 2 > income Statement > eps
-2.8703640199254528
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
53933229
Annuals > 2 > income Statement > income Tax Expense
-2977000
Annuals > 2 > income Statement > EBITDA
-151655000
Annuals > 2 > income Statement > operating Margin
-344.3727843505745
Annuals > 2 > income Statement > total Other Income Expense Net
6448000
Annuals > 2 > balance Sheet > cash
68395000
Annuals > 2 > balance Sheet > short Term Investments
338771000
Annuals > 2 > balance Sheet > receivables
2537000
Annuals > 2 > balance Sheet > inventories
-12250000
Annuals > 2 > balance Sheet > total Current Assets
419416000
Annuals > 2 > balance Sheet > property Plant Equipment
22243000
Annuals > 2 > balance Sheet > total Assets
603134000
Annuals > 2 > balance Sheet > payables
4335000
Annuals > 2 > balance Sheet > short Term Debt
3943000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
112983000
Annuals > 2 > balance Sheet > equity
490151000
Annuals > 2 > cash Flow > net Income
-154808000
Annuals > 2 > cash Flow > depreciation
2977000
Annuals > 2 > cash Flow > change In Working Capital
-37623000
Annuals > 2 > cash Flow > cash From Operations
-153085000
Annuals > 2 > cash Flow > capital Expenditures
2836000
Annuals > 2 > cash Flow > cash From Investing
20519000
Annuals > 2 > cash Flow > cash From Financing
152999000
Annuals > 2 > cash Flow > net Change In Cash
20433000
Annuals > 2 > ratios > PE
-2.8703640199254528
Annuals > 2 > ratios > PB
7.469101530997589
Annuals > 2 > ratios > ROE
-31.583736440403058
Annuals > 2 > ratios > ROA
-25.667264654289095
Annuals > 2 > ratios > FCF
-155921000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-3.329795412804852
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
72832000
Annuals > 3 > income Statement > cost Of Revenue
2397000
Annuals > 3 > income Statement > gross Profit
72832000
Annuals > 3 > income Statement > operating Expenses
173362000
Annuals > 3 > income Statement > operating Income
-100530000
Annuals > 3 > income Statement > interest Expense
175000
Annuals > 3 > income Statement > pretax Income
-100217000
Annuals > 3 > income Statement > net Income
-100217000
Annuals > 3 > income Statement > eps
-2.0883317420319227
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
47989023
Annuals > 3 > income Statement > income Tax Expense
-2222000
Annuals > 3 > income Statement > EBITDA
-97645000
Annuals > 3 > income Statement > operating Margin
-138.02998681898066
Annuals > 3 > income Statement > total Other Income Expense Net
313000
Annuals > 3 > balance Sheet > cash
47976000
Annuals > 3 > balance Sheet > short Term Investments
394442000
Annuals > 3 > balance Sheet > receivables
135000
Annuals > 3 > balance Sheet > inventories
-8990000
Annuals > 3 > balance Sheet > total Current Assets
451273000
Annuals > 3 > balance Sheet > property Plant Equipment
21307000
Annuals > 3 > balance Sheet > total Assets
605905000
Annuals > 3 > balance Sheet > payables
4005000
Annuals > 3 > balance Sheet > short Term Debt
3599000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
146267000
Annuals > 3 > balance Sheet > equity
459638000
Annuals > 3 > cash Flow > net Income
-100217000
Annuals > 3 > cash Flow > depreciation
2397000
Annuals > 3 > cash Flow > change In Working Capital
-61923000
Annuals > 3 > cash Flow > cash From Operations
-128946000
Annuals > 3 > cash Flow > capital Expenditures
1597000
Annuals > 3 > cash Flow > cash From Investing
-99835000
Annuals > 3 > cash Flow > cash From Financing
250280000
Annuals > 3 > cash Flow > net Change In Cash
21499000
Annuals > 3 > ratios > PE
-2.0883317420319227
Annuals > 3 > ratios > PB
7.087087841388223
Annuals > 3 > ratios > ROE
-21.803462725014032
Annuals > 3 > ratios > ROA
-16.54005165826326
Annuals > 3 > ratios > FCF
-130543000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-1.7923852152899824
Annuals > 3 > health Score
27
Valuation > metrics > PE
-0.941291303444298
Valuation > metrics > PB
8.273736812243596
Valuation > final Score
20
Valuation > verdict
175.8% Overvalued
Profitability > metrics > ROE
-8.684206632863342
Profitability > metrics > ROA
-15.554668009343212
Profitability > metrics > Net Margin
-29.730463096960925
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.16463374682169132
Risk > metrics > Interest Coverage
-944.0918367346939
Risk > final Score
-3716
Risk > verdict
High
Liquidity > metrics > Current Ratio
27.44547768715258
Liquidity > metrics > Quick Ratio
27.44547768715258
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-3072
Prev Risks > 1
-4075
Prev Risks > 2
-5415
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:45:18.404Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-10-29
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-0.94
Earnings History > 0 > eps Estimate
-0.8613
Earnings History > 0 > eps Difference
-0.0787
Earnings History > 0 > surprise Percent
-9.1374
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-11
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.95
Earnings History > 1 > eps Estimate
-0.83
Earnings History > 1 > eps Difference
-0.12
Earnings History > 1 > surprise Percent
-14.4578
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-04-30
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.82
Earnings History > 2 > eps Estimate
-0.73
Earnings History > 2 > eps Difference
-0.09
Earnings History > 2 > surprise Percent
-12.3288
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-20
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.89
Earnings History > 3 > eps Estimate
-0.7882
Earnings History > 3 > eps Difference
-0.1018
Earnings History > 3 > surprise Percent
-12.9155
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-10-31
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.82
Earnings History > 4 > eps Estimate
-0.84
Earnings History > 4 > eps Difference
0.02
Earnings History > 4 > surprise Percent
2.381
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-07
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.58
Earnings History > 5 > eps Estimate
-0.68
Earnings History > 5 > eps Difference
0.1
Earnings History > 5 > surprise Percent
14.7059
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-02
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.62
Earnings History > 6 > eps Estimate
-0.73
Earnings History > 6 > eps Difference
0.11
Earnings History > 6 > surprise Percent
15.0685
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-22
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.25
Earnings History > 7 > eps Estimate
-0.4
Earnings History > 7 > eps Difference
0.15
Earnings History > 7 > surprise Percent
37.5
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-02
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.9
Earnings History > 8 > eps Estimate
-0.64
Earnings History > 8 > eps Difference
-0.26
Earnings History > 8 > surprise Percent
-40.625
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-03
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.67
Earnings History > 9 > eps Estimate
-0.71
Earnings History > 9 > eps Difference
0.04
Earnings History > 9 > surprise Percent
5.6338
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-04
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.7
Earnings History > 10 > eps Estimate
-0.68
Earnings History > 10 > eps Difference
-0.02
Earnings History > 10 > surprise Percent
-2.9412
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-02-23
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.6
Earnings History > 11 > eps Estimate
-0.63
Earnings History > 11 > eps Difference
0.03
Earnings History > 11 > surprise Percent
4.7619
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-03
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.79
Earnings History > 12 > eps Estimate
-0.74
Earnings History > 12 > eps Difference
-0.05
Earnings History > 12 > surprise Percent
-6.7568
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-09
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.78
Earnings History > 13 > eps Estimate
-0.7
Earnings History > 13 > eps Difference
-0.08
Earnings History > 13 > surprise Percent
-11.4286
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-03
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.71
Earnings History > 14 > eps Estimate
-0.66
Earnings History > 14 > eps Difference
-0.05
Earnings History > 14 > surprise Percent
-7.5758
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-02-24
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.66
Earnings History > 15 > eps Estimate
-0.57
Earnings History > 15 > eps Difference
-0.09
Earnings History > 15 > surprise Percent
-15.7895
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-10
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.56
Earnings History > 16 > eps Estimate
-0.42
Earnings History > 16 > eps Difference
-0.14
Earnings History > 16 > surprise Percent
-33.3333
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-06
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.55
Earnings History > 17 > eps Estimate
-0.29
Earnings History > 17 > eps Difference
-0.26
Earnings History > 17 > surprise Percent
-89.6552
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-06
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.29
Earnings History > 18 > eps Estimate
-0.15
Earnings History > 18 > eps Difference
-0.14
Earnings History > 18 > surprise Percent
-93.3333
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-11
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.29
Earnings History > 19 > eps Estimate
-0.04
Earnings History > 19 > eps Difference
-0.25
Earnings History > 19 > surprise Percent
-625
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-05
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.39
Earnings History > 20 > eps Estimate
-0.21
Earnings History > 20 > eps Difference
-0.18
Earnings History > 20 > surprise Percent
-85.7143
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-21
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.42
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-06-22
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.96
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.96
Earnings History > 22 > surprise Percent
-
Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa and atopic dermatitis. The company also develops STAT6, a type 2 inflammation in allergic and atopic diseases; and TYK2 to treat autoimmune and inflammatory diseases. The company has a strategic alliance with Sanofi S.A. for the development of drug candidates targeting IRAK4 outside of the oncology and immuno-oncology fields. Kymera Therapeutics, Inc. was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AKymera Therapeutics (NASDAQ:KYMR) Director Bruce Booth Sells 678 Shares MarketBeat
Read more →Insider Selling: Kymera Therapeutics (NASDAQ:KYMR) Director Sells 6,101 Shares of Stock - MarketBeat
12/14/2025
Insider Selling: Kymera Therapeutics (NASDAQ:KYMR) Director Sells 6,101 Shares of Stock MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$77.5909
Analyst Picks
Strong Buy
14
Buy
3
Hold
3
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 118.76% of the total shares of Kymera Therapeutics Inc
1.
T. Rowe Price Associates, Inc.(9.5936%)
since
2025/06/30
2.
Baker Bros Advisors LP(9.303%)
since
2025/06/30
3.
venBio Select Advisor LLC(9.1689%)
since
2025/06/30
4.
Vanguard Group Inc(7.8602%)
since
2025/06/30
5.
Bvf Inc(7.6964%)
since
2025/06/30
6.
FMR Inc(7.5974%)
since
2025/06/30
7.
Wellington Management Company LLP(7.5136%)
since
2025/06/30
8.
BlackRock Inc(5.802%)
since
2025/06/30
9.
Siren, L.L.C.(4.7948%)
since
2025/06/30
10.
US Small-Cap Growth II Equity Comp(4.058%)
since
2025/06/30
11.
T. Rowe Price New Horizons(3.7277%)
since
2025/07/31
12.
Vanguard Health Care Inv(3.3386%)
since
2025/06/30
13.
Fidelity Growth Compy Commingled Pl S(3.2949%)
since
2025/07/31
14.
Vanguard Total Stock Mkt Idx Inv(2.6272%)
since
2025/07/31
15.
Fidelity Growth Company Fund(2.2955%)
since
2025/07/31
16.
State Street Corp(2.1741%)
since
2025/06/30
17.
Vanguard Small Cap Index(2.027%)
since
2025/07/31
18.
Capital Research Global Investors(1.7653%)
since
2025/06/30
19.
T. Rowe Price Health Sciences(1.6853%)
since
2025/07/31
20.
Geode Capital Management, LLC(1.6687%)
since
2025/06/30
21.
iShares Russell 2000 ETF(1.5776%)
since
2025/08/31
22.
American Funds SMALLCAP World A(1.5558%)
since
2025/06/30
23.
Vanguard Explorer Inv(1.3677%)
since
2025/06/30
24.
Driehaus Capital Management LLC(1.3062%)
since
2025/06/30
25.
T. Rowe Price New Horizons Tr-A(1.3032%)
since
2025/06/30
26.
Jennison Associates LLC(1.1539%)
since
2025/06/30
27.
UBS Asset Mgmt Americas Inc(1.1454%)
since
2025/06/30
28.
Vanguard Small Cap Growth Index Inv(1.1444%)
since
2025/07/31
29.
Redmile Group, LLC(1.1235%)
since
2025/06/30
30.
Merck & Co Inc(1.08%)
since
2025/06/30
31.
COMMODORE CAPITAL LP(1.049%)
since
2025/06/30
32.
Deerfield Management Co(0.9133%)
since
2025/06/30
33.
T. Rowe Price Integrated US SmCapGrEq(0.7983%)
since
2025/06/30
34.
Dimensional Fund Advisors, Inc.(0.7879%)
since
2025/06/30
35.
Eventide Healthcare & Life Sciences I(0.7874%)
since
2025/06/30
36.
Vanguard Institutional Extnd Mkt Idx Tr(0.78%)
since
2025/07/31
37.
T. Rowe Price Integrated US Sm Gr Eq(0.7496%)
since
2025/07/31
38.
PGIM Jennison Health Sciences Z(0.7322%)
since
2025/07/31
39.
Jennison Health Sciences Equity(0.7322%)
since
2025/06/30
40.
SPDR® S&P Biotech ETF(0.6839%)
since
2025/08/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.94
EPS Estimate
-0.8613
EPS Difference
-0.0787
Surprise Percent
-9.1374%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.